AMGEN Inc
NASDAQ: AMGN
$283.61
-$12.32 (-4.2%)
Closing Price on November 15, 2024
AMGN Articles
Tuesday's top analyst upgrades and downgrades included Airbnb, Amgen, Aramark, Arm, Datadog, Delta Air Lines, Match, Oracle, Patterson-UTI Energy, PayPal, Spotify Technology, Unity Software and...
Published:
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Published:
Thursday's top analyst upgrades and downgrades included American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines, Taiwan Semiconductor Manufacturing and Toast.
Published:
Thursday's top analyst upgrades and downgrades included Amazon.com, American Electric Power, Amgen, BHP, Duke Energy, General Mills, KeyCorp, Lowe's Companies, Macy's, Marvell Technology, Netflix,...
Published:
Tuesday's top analyst upgrades and downgrades included Amgen, CF Industries, Coterra Energy, CymaBay Therapeutics, Eaton, Marriott, Monster Beverage, Mosaic, Nutrien, Public Service Enterprise, Urban...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
Published:
The highest-yielding stocks in the Nasdaq offer a contrarian angle for the rest of 2023. They all have some solid defensive qualities, and they are offering among the best entry points seen in some...
Published:
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot,...
Published:
With more banks failing and interest rates still rising, it may be time to take profits on the mega-cap winners and move to safer old-school stocks that can survive an economic downturn. These five...
Published:
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Published:
Thursday's top analyst upgrades and downgrades included Amgen, Arista Networks, Bloom Energy, ConocoPhillips, Fastenal, Livent, On Holding, Palo Alto Networks, SLM, UnitedHealth, Vici Properties and...
Published:
With the second quarter now underway, these seven top dividend-paying Goldman Sachs stock picks make sense for growth and income investors who are looking for stocks that are still offering...
Published:
Given that the Nasdaq has only twice had two down years in a row, the five highest-yielding stocks in the index offer a contrarian angle for 2023 for growth and income investors looking for a way...
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published:
Tuesday's top analyst upgrades and downgrades included Amgen, Caterpillar, CF Industries, Coinbase Global, Fastly, Match, Newmont, Okta, Progressive, Toast, Under Armour, Walt Disney and Zim...
Published: